Vimarsana
Biggest News Aggregation in the World

Page 27 - Director Patrick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Patrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Patrick Today - Breaking & Trending Today

Final piece of $1.1 billion rebuild of I-75 dedicated - Vimarsana News

Final piece of $1.1 billion rebuild of I-75 dedicated

A $1.1 billion investment in rebuilding Interstate 75 from Lima to Toledo is wrapping up with the opening of the Michael DiSalle Bridge.

Amplitude (NASDAQ:AMPL) Updates FY23 Earnings Guidance - Vimarsana News

Amplitude (NASDAQ:AMPL) Updates FY23 Earnings Guidance

Amplitude (NASDAQ:AMPL – Get Free Report) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.02-0.04 for the period, compared to the consensus earnings per share estimate of $0.04. The company issued revenue guidance of $273.6-275.6 million, compared to the consensus revenue estimate of $267.89 […]

Amplitude (NASDAQ:AMPL) Updates FY23 Earnings Guidance - Vimarsana News

Amplitude (NASDAQ:AMPL) Updates FY23 Earnings Guidance

Amplitude (NASDAQ:AMPL – Get Free Report) updated its FY23 earnings guidance on Tuesday. The company provided earnings per share guidance of $0.02-0.04 for the period, compared to the consensus earnings per share estimate of $0.04. The company issued revenue guidance of $273.6-275.6 million, compared to the consensus revenue estimate of $267.89 million. Amplitude also updated […]

Source: wkrb13.com
Roseburg VA Health Care Systems received 5-star rating - Vimarsana News

Roseburg VA Health Care Systems received 5-star rating

Roseburg VA Health Care Systems announced Thursday that it received a five-star rating, the highest possible rating, from the Centers for Medicare & Medicaid Services.

Chemed (NYSE:CHE) PT Lowered to $576.00 - Vimarsana News

Chemed (NYSE:CHE) PT Lowered to $576.00

Chemed (NYSE:CHE – Free Report) had its target price lowered by Royal Bank of Canada from $610.00 to $576.00 in a research report report published on Monday, Marketbeat.com reports. The firm currently has an outperform rating on the stock. A number of other equities analysts also recently weighed in on CHE. Oppenheimer upped their target […]

Source: wkrb13.com